1 day Ago By Defense World Staff
Arrowstreet Capital Limited Partnership lessened its stake in Medifast, Inc. ( NYSE:MED – Free Report ) by 77.8% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission.
The fund owned 51,396 shares of the specialty retailer’s stock after selling 180,332 shares during the quarter. Arrowstreet Capital Limited Partnership owned about 0.47% of Medifast worth $906,000 as of its most recent SEC filing.
Other hedge funds have also recently added to or reduced their stakes in the company. Public Employees Retirement System of Ohio lifted its stake in Medifast by 1,161.8% in the third quarter.
Public Employees Retirement System of Ohio now owns 9,766 shares of the specialty retailer’s stock valued at $187,000 after buying an additional 8,992 shares in the last quarter. Nisa Investment Advisors LLC lifted its position in Medifast by 2,308.8% in the 4th quarter.
Nisa Investment Advisors LLC now owns 11,442 shares of the specialty retailer’s stock valued at $202,000 after acquiring an additional 10,967 shares in the last quarter. Exchange Traded Concepts LLC lifted its position in Medifast by 4.1% in the 4th quarter.
Exchange Traded Concepts LLC now owns 17,106 shares of the specialty retailer’s stock valued at $301,000 after acquiring an additional 674 shares in the last quarter. XTX Topco Ltd acquired a new position in Medifast in the 3rd quarter worth $348,000. Finally, Amundi bought a new position in Medifast during the 4th quarter worth about $374,000.
Institutional investors and hedge funds own 95.51% of the company’s stock. Wall Street Analysts Forecast Growth Separately, DA Davidson reduced their price objective on Medifast from $17.
00 to $16.50 and set a “neutral” rating for the company in a research report on Wednesday, February 19th. Medifast Stock Down 3.
6 % Shares of MED opened at $12.66 on Friday. Medifast, Inc.
has a twelve month low of $12.30 and a twelve month high of $36.30.
The stock has a market capitalization of $138.52 million, a P/E ratio of 70.36 and a beta of 1.
05. The company has a 50 day moving average of $14.21 and a 200-day moving average of $16.
60. Medifast ( NYSE:MED – Get Free Report ) last released its earnings results on Tuesday, February 18th. The specialty retailer reported $0.
10 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.16) by $0.26.
Medifast had a net margin of 0.35% and a return on equity of 10.64%.
The business had revenue of $119.00 million during the quarter, compared to the consensus estimate of $114.25 million.
On average, sell-side analysts anticipate that Medifast, Inc. will post 0.51 earnings per share for the current fiscal year.
About Medifast ( Free Report ) Medifast, Inc, through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names. Further Reading Five stocks we like better than Medifast How to Evaluate a Stock Before Buying Robinhood Strategies Could Be a Game-Changer for Young Investors How to Plot Fibonacci Price Inflection Levels Are These 3 Retail Stocks Oversold or Really in Trouble? 3 Grocery Stocks That Can Help Take a Bite Out of Inflation IONQ & RGTI Join DARPA Quantum Initiative: High Stakes Are Ahead Want to see what other hedge funds are holding MED? Visit HoldingsChannel.
com to get the latest 13F filings and insider trades for Medifast, Inc. ( NYSE:MED – Free Report ). Receive News & Ratings for Medifast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medifast and related companies with MarketBeat.
com's FREE daily email newsletter ..
